01:02

Doxycycline | Time to begin before travel | Time to end after travel | Q 113 | Mrcgp

01:11

Doxycycline side effects | oseophagitis + photosenstivity | Q 112 | Mrcgp

01:03

Chloroquine | Time to begin before travel | Time to end after travel | Q 111 | Mrcgp

01:04

Atovaquone | Time to begin before travel | Time to end after travel | Q 107 | Mrcgp

01:14

Statement regarding Malaria | True | Q 105 | Mrcgp

01:21

Multiple non healing ulcer + Pale conjunctiva + bleeding gums | ?? | Q 104 | Mrcgp

01:18

UTI | Past Epilepsy on sodium valproate | Antibiotic should avoid | Q 103 | Mrcgp

01:21

Contacts of confirmed chlamydia cases | should be offered treatment | ?? | Mrcgp | Q 102

01:10

For women with symptomatic chlamydia infection but asymptomatic man | partners notification | Q 101

01:22

For men with symptomatic chlamydia infection | which partners should be contacted | Q 100 | Mrcgp

01:14

Patient diagnosed with chlamydia | Initial partner notification | Q 99 | Mrcgp

01:03

Chlamydia | Treatment | if patient is pregnant | Q 98 | Mrcgp

01:58

Chlamydia | ist line Antibiotic | Azithromycin or Doxycycline | Q 98 | Mrcgp

01:07

Chlamydia | Management | Azithromycin or Doxycycline | Q 97 | Mrcgp

01:07

Chlamydia | Screening | All men + women aged 15 - 24 years | Q 95 | Mrcgp

01:05

Chlamydia | Invesigation of choice | Q 94 | Naats | Mrcgp

01:28

Chlamydia | Clinical Features | Q 93 | Mrcgp

01:20

Chlamydia | Appropriate management | Chlamydia testing + Antibiotic treatment without waiting result

01:18

Prostate cancer | Clinical Features | Q 91 | Mrcgp

01:06

Second most common cause of death after lung cancer | Prostate cancer | Q 88 | Mrcgp

01:06

Most common cancer in Male adults in UK | prostate cancer | Q 87 | Mrcgp

01:03

If PSA increasing | Urgent referral | Q 86 | Mrcgp

01:03

Asymptomatic patient | With PSA at upper limit of normal | Q 85 | Mrcgp

02:04

Colorectal cancer screening | Q 82 |Mrcgp

01:03

Positive Faecal occult blood test | Colorectal cancer | Q 81 | Mrcgp

02:31

Digital rectal exam & PSA test | Q 79 | Mrcgp

00:33

Diabetes Mellitus | Type 2 | impaired glucose tolerance | Q 78 | MRCGP

00:33

Diabetes Mellitus | type 2 | impaired fasting glucose | Q 77 | MRCGP

00:33

Diabetes Mellitus | Nice guidelines for Thiazolidinodiones | Q 76 | MRCGP

00:33

Diabetes Mellitus type 2 | Glycaemic control poor | Medication increases insulin sensitivity | Q 75|

00:33

Diabetes Mellitus type 2 | if patient is symptomatic | Fasting & Random glucose | Q 74 | MRCGP

00:33

Diabetes Mellitus type 2 | HbA1c | Stable patients | Q 73 | MRCGP

00:33

Diabetes Mellitus type 2 | HbA1c | Q 72 | MRCGP

00:33

Absent Ankle Reflex | S1 - S2 | Q 71 | MRCGP

00:33

Absent Knee Reflex | L3 - L4 | Q 70 | MRCGP

00:33

Absent Triceps Reflex | C7 - C8 | Q 69 | MRCGP

00:33

Absent Biceps Reflex | C5 -C6 | Q 68 | MRCGP

00:33

Addisons disease | Treatment | intercurrent illness | Q 66 | MRCGP

00:33

Addisons disease | Treatment | patient Education | Q 65 | MRCGP

00:33

Addisons disease | Treatment | Hydrocortisone | Q 64 | MRCGP

00:34

Addisons disease | Treatment | Combination therapy | Q 63 | MRCGP

00:33

Addisons disease | Treatment | Q 62 | MRCGP

00:33

Addisons disease | Electrolyte abnormalities | Best medical mnemonics | Q 61 | MRCGP

00:33

Addisons disease | lab investigation | Serum cortisol | Q 60 | MRCGP

00:33

Addisons disease | 9 AM serum cortisol | Q 59 | MRCGP

00:33

Addisons disease | important marker | Adrenal autoantibodies | Anti 21 Hydroxylase | Q 57 | MRCGP

00:33

Addisons disease | plasma cortisol measurement | Q 56 | MRCGP

00:33

Addisons disease | Definitive investigation | Q 55 | MRCGP

00:34

Hypoadrenalism | one more cause | Q 54 MRCGP

00:33

Secondary cause of Hypoadrenalism | Q 53 | MRCGP

00:33

Primary cause of Hypoadrenalism | Q 52 | Best medical mnemonics | MRCGP

00:33

Addisons disease | crises | Q 51 | Best medical mnemonics | important Q | MRCGP

00:34

Addisons disease | Features | Q 50 | important Q | MRCGP

00:33

Addisons disease | Hypoadrenalism | cause | Q 49 | important Q | MRCGP

00:33

Acute Promyelocytic leukemia | presentation + prognosis | Q 48 | important Q | MRCGP

00:33

Acute Promyelocytic leukemia | Younger + Fusion | Q 47 | important Q | MRCGP

00:33

Acute Promyelocytic leukemia | M3 | Association + Auer | Q 46 | important Q | MRCGP

00:33

Acute Myeloid leukemia | Classification | M6 M7 | Q 44 | important Q | MRCGP

00:33

Acute Myeloid leukemia | Classification | M4 M5 | Q 43 | important Q | MRCGP

00:32

Acute Myloid leukemia | Classification | M3 - Acute Promyelocytic Leukemia | Q 42 | MRCGP